ABVC BioPharma, Inc. Business Combination, Consideration Transferred, Other
ABVC BioPharma, Inc. (ECOC) reported Business Combination, Consideration Transferred, Other of $44.34 million for the 0-month period ending 2019-02-08, per its 10-K filed 2021-03-16.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferredOther1 · last filed 2021-11-15
- ABVC BioPharma, Inc. business combination, consideration transferred, other for fiscal 2018 was $44.34M.
| Period end | Business Combination, Consideration Transferred, Other 0 month | Business Combination, Consideration Transferred, Other 12 month |
|---|---|---|
| 2019-02-08 | $44.34M 10-K · filed 2021-03-16 | |
| 2018-12-31 | $44.34M 10-K · filed 2019-04-15 |